GSK
Science-led global healthcare co with a special purpose: to help people to do more, feel better, live longer.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
$18.0m | Grant | ||
| Total Funding | 000k | ||
| GBP | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (14 %) | 3 % | 3 % | 3 % | 6 % | 4 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 26 % | 30 % | 32 % | 26 % | 34 % | 35 % | 35 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 13 % | 51 % | 16 % | 8 % | 18 % | 19 % | 19 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 15 % | 19 % | 21 % | 20 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
GSK (GlaxoSmithKline) is a global healthcare company focused on improving the quality of human life by developing innovative medicines, vaccines, and consumer healthcare products. The company operates in three primary areas: Pharmaceuticals, Vaccines, and Consumer Healthcare. GSK serves a wide range of clients, including patients, healthcare professionals, and governments worldwide.
In the Pharmaceuticals segment, GSK researches and develops medicines to treat various diseases, including respiratory conditions, HIV, oncology, and immuno-inflammation. The Vaccines segment focuses on creating vaccines to prevent illnesses such as influenza, shingles, and COVID-19. The Consumer Healthcare division offers over-the-counter products for wellness, oral health, nutrition, and skin health.
GSK operates in the highly competitive and regulated global healthcare market. The company’s business model revolves around extensive research and development (R&D) to bring new products to market. GSK invests heavily in scientific innovation to stay ahead of emerging health threats and meet the evolving needs of patients.
GSK generates revenue primarily through the sale of its pharmaceutical products, vaccines, and consumer healthcare items. The company also collaborates with other biotech firms and governments, which can include agreements for the purchase of treatments, such as their COVID-19 therapy, sotrovimab. Additionally, GSK offers support programs to help patients afford their medications, ensuring broader access to their products.
In summary, GSK is a science-led healthcare company dedicated to developing and delivering a wide range of innovative products that improve health outcomes globally. The company’s commitment to R&D, strategic partnerships, and patient support programs are key drivers of its growth and performance.
Keywords: Pharmaceuticals, Vaccines, Consumer Healthcare, Innovation, Research, Development, Global, Medicines, Treatments, Healthcare.
Tech stack
